Neuland Laboratories Faces Significant Stock Volatility Amid Market Challenges

Neuland Laboratories, a midcap player in the Pharmaceuticals & Drugs industry, has experienced significant volatility today, with its stock price declining by 5.62% as of February 11, 2025. The stock opened lower, down 4.97%, and reached an intraday low of Rs 13,709.7, marking a decrease of 6.51% at its lowest point.
In terms of performance metrics, Neuland Laboratories underperformed its sector by 5.76%. Over the past month, the stock has seen a slight decline of 1.31%, contrasting with the Sensex, which fell by only 0.32%. Additionally, the stock's intraday volatility was notably high at 41.68%, indicating significant price fluctuations throughout the trading session.

When examining moving averages, Neuland Laboratories remains above its 200-day moving average but is currently below its 5-day, 20-day, 50-day, and 100-day moving averages. This mixed performance highlights the challenges the company faces in the current market environment.